New blood tests could replace painful bone marrow checks for rare cancer
NCT ID NCT03952052
Summary
This study aimed to find better ways to monitor Waldenström's disease, a rare blood cancer. Researchers tested new, sensitive blood tests to track a common cancer-related mutation, hoping to see if they could replace more invasive bone marrow biopsies. The goal was to improve how doctors follow the disease and its response to treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WALDENSTROM'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Henri Becquerel
Rouen, 76000, France
Conditions
Explore the condition pages connected to this study.